22 October 2026
Latham & Watkins Advises Cheplapharm on Private Placement
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Rüdiger Malaun Lead | Latham & Watkins LLP | Partner | Capital Markets | Munich |
| Jan Penselin Lead | Latham & Watkins LLP | Partner | Capital Markets | Frankfurt |
| Peter Neuböck | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Tobias Müller | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Ulf Kieker | Latham & Watkins LLP | Partner | tax | Munich |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 390m (€390 million)
- What the figure measures
- Issue size
- Client
- Cheplapharm Arzneimittel GmbHIssuer
- Counterparties
- Not stated